Literature DB >> 10993647

Identification of MEN1 gene mutations in families with MEN 1 and related disorders.

L Bergman1, B Teh, J Cardinal, J Palmer, M Walters, J Shepherd, D Cameron, N Hayward.   

Abstract

Following identification of the MEN1 gene, we analysed patients from 12 MEN 1 families, 8 sporadic cases of MEN 1, and 13 patients with MEN 1-like symptoms (e.g. cases of familial isolated hyperparathyroidism (FIHPT), familial acromegaly, or atypical MEN 1 cases) for the presence of germline MEN1 mutations. The entire coding region of the MEN1 gene was sequenced, and mutations were detected in 11 MEN 1 families; one sporadic MEN 1 patient, one case of FIHPT and one MEN 1-like case. Constitutional DNA samples from individuals without MEN1 mutations were digested with several restriction enzymes, Southern blotted and probed with MEN1 cDNA to analyse for the presence of larger deletions of the MEN1 gene unable to be detected by PCR. One MEN 1 patient was found to carry such a deletion. This patient was heterozygous for the D418D polymorphism, however sequence analysis of RT-PCR products showed that only the variant allele was transcribed, thus confirming the result obtained by Southern analysis, which indicated loss of a region containing the initiation codon of one allele. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993647      PMCID: PMC2363562          DOI: 10.1054/bjoc.2000.1380

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Characterization of mutations in patients with multiple endocrine neoplasia type 1.

Authors:  J H Bassett; S A Forbes; A A Pannett; S E Lloyd; P T Christie; C Wooding; B Harding; G M Besser; C R Edwards; J P Monson; J Sampson; J A Wass; M H Wheeler; R V Thakker
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

2.  Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

Authors:  I Lemmens; W J Van de Ven; K Kas; C X Zhang; S Giraud; V Wautot; N Buisson; K De Witte; J Salandre; G Lenoir; M Pugeat; A Calender; F Parente; D Quincey; P Gaudray; M J De Wit; C J Lips; J W Höppener; S Khodaei; A L Grant; G Weber; S Kytölä; B T Teh; F Farnebo; R V Thakker
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

3.  Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.

Authors:  S K Agarwal; M B Kester; L V Debelenko; C Heppner; M R Emmert-Buck; M C Skarulis; J L Doppman; Y S Kim; I A Lubensky; Z Zhuang; J S Green; S C Guru; P Manickam; S E Olufemi; L A Liotta; S C Chandrasekharappa; F S Collins; A M Spiegel; A L Burns; S J Marx
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

Review 4.  Multiple endocrine neoplasia type I: clinical syndrome to molecular genetics.

Authors:  B T Teh; S Grimmond; J Shepherd; C Larsson; N Hayward
Journal:  Aust N Z J Surg       Date:  1995-10

5.  Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.

Authors:  T N Darling; M C Skarulis; S M Steinberg; S J Marx; A M Spiegel; M Turner
Journal:  Arch Dermatol       Date:  1997-07

6.  Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.

Authors:  S Giraud; C X Zhang; O Serova-Sinilnikova; V Wautot; J Salandre; N Buisson; C Waterlot; C Bauters; N Porchet; J P Aubert; P Emy; G Cadiot; B Delemer; O Chabre; P Niccoli; F Leprat; F Duron; B Emperauger; P Cougard; P Goudet; E Sarfati; J P Riou; S Guichard; M Rodier; A Meyrier; P Caron; M C Vantyghem; M Assayag; J L Peix; M Pugeat; V Rohmer; M Vallotton; G Lenoir; P Gaudray; C Proye; B Conte-Devolx; P Chanson; Y Y Shugart; D Goldgar; A Murat; A Calender
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

Review 7.  Pathology of MEN-1: morphology, clinicopathologic correlations and tumour development.

Authors:  P Komminoth; P U Heitz; G Klöppel
Journal:  J Intern Med       Date:  1998-06       Impact factor: 8.989

8.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

Authors:  C Larsson; B Skogseid; K Oberg; Y Nakamura; M Nordenskjöld
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

9.  A large germline deletion of the MEN1 gene in a family with multiple endocrine neoplasia type 1.

Authors:  M Kishi; T Tsukada; S Shimizu; H Futami; Y Ito; M Kanbe; T Obara; K Yamaguchi
Journal:  Jpn J Cancer Res       Date:  1998-01

10.  Germline mutations of the MEN1 gene in Japanese kindred with multiple endocrine neoplasia type 1.

Authors:  S Shimizu; T Tsukada; H Futami; K Ui; T Kameya; M Kawanaka; S Uchiyama; A Aoki; H Yasuda; S Kawano; Y Ito; M Kanbe; T Obara; K Yamaguchi
Journal:  Jpn J Cancer Res       Date:  1997-11
View more
  13 in total

1.  Menin immunoreactivity in secretory granules of human pancreatic islet cells.

Authors:  Larisa V Debelenko; Sunita Agarwal; Qiang Du; Wusheng Yan; Heidi S Erickson; Mones Abu-Asab; Mark A Raffeld; Steven K Libutti; Stephen J Marx; Michael R Emmert-Buck
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014 Nov-Dec

2.  A novel germline mutation of MEN 1 gene in a patient with acromegaly and multiple endocrine tumors.

Authors:  G Pinna; G Orgiana; C Carcassi; F Alba; F Cetani; E Pardi; C Marcocci; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 3.  Genetic basis of familial isolated hyperparathyroidism: a case series and a narrative review of the literature.

Authors:  Nikolaos Pontikides; Spyridon Karras; Athina Kaprara; Panagiotis Anagnostis; Gesthimani Mintziori; Dimitrios G Goulis; Eleni Memi; Gerasimos Krassas
Journal:  J Bone Miner Metab       Date:  2014-01-19       Impact factor: 2.626

4.  Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism.

Authors:  Viive M Howell; John W Cardinal; Anne-Louise Richardson; Oliver Gimm; Bruce G Robinson; Deborah J Marsh
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

Review 5.  The MEN1 gene and associated diseases: an update.

Authors:  T Tsukada; K Yamaguchi; T Kameya
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

6.  Isolated familial somatotropinoma.

Authors:  Beatriz Santana Soares; Lawrence A Frohman
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

7.  A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing.

Authors:  J W Cardinal; L Bergman; N Hayward; A Sweet; J Warner; L Marks; D Learoyd; T Dwight; B Robinson; M Epstein; M Smith; B T Teh; D P Cameron; J B Prins
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

8.  Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression.

Authors:  Maria Chiara Zatelli; Federico Tagliati; Mauro Di Ruvo; Emilie Castermans; Luigi Cavazzini; Adrian F Daly; Maria Rosaria Ambrosio; Albert Beckers; Ettore degli Uberti
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 9.  Multiple Endocrine Neoplasia: A Genetically Diverse Group of Familial Tumor Syndromes.

Authors:  M Cristina Pacheco
Journal:  J Pediatr Genet       Date:  2016-03-09

10.  Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism.

Authors:  Trisha Dwight; Anne E Nelson; George Theodosopoulos; Anne Louise Richardson; Diana L Learoyd; Jeanette Philips; Leigh Delbridge; Jan Zedenius; Bin T Teh; Catharina Larsson; Deborah J Marsh; Bruce G Robinson
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.